BUCHAN CONSULTING PTY LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Triad Life Sciences completes A$25m funding round, anticipates ASX listing in coming months 2021-08-30 09:18
Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's 2021-08-04 20:39
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report 2021-07-30 21:05
Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function 2021-07-15 21:52
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's 2021-07-01 19:50
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2021-06-23 21:21
Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report 2021-04-29 20:30
SenSen: North American Operations and Expansion Update 2021-04-22 09:00
ATH434 protects brain cells and improves motor function in Parkinsonian disorder 2021-04-21 20:11
Alterity to present at the 7th International Congress of Multiple System Atrophy 2021-02-26 20:45
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials 2021-02-09 21:53
Medibio Granted CE Mark Approval for MEBsleep 2021-01-19 21:06
Dr David Stamler Appointed CEO 2021-01-07 21:00
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics 2020-12-22 05:42
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-17 01:09
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-16 21:42
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies 2020-10-26 08:37
New data independently confirms and extends laboratory findings and expands safety profile of ATH434 2020-08-04 09:33
Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report 2020-07-31 06:49
1 2 3 4